Zusammenfassung
Kernmerkmal der BN ist ein übermäßiger Verzehr von Nahrungsmitteln im Sinne von regelmäßig wiederkehrenden Essanfällen. Unter einem Essanfall wird der Verzehr von ungewöhnlich großen Nahrungsmengen in einer bestimmten Zeitspanne verstanden (z. B. innerhalb eines Zeitraums von 2 Stunden). Dabei handelt es sich häufig um leicht verfügbare kalorienreiche Nahrungsmittel, die bei der regulären Ernährung meistens vermieden werden (z. B. Süßigkeiten). An einer BN leidende Personen berichten des Weiteren, dass sie sich den Essanfällen gegenüber ausgeliefert fühlen bzw. dass sie keine Kontrolle darüber haben, wie viel und was sie essen. Selbst bei einem starken Völlegefühl ist es ihnen nicht möglich, mit dem Essen aufzuhören. Allerdings können Essanfälle auch aktiv beendet und später fortgesetzt werden (z. B. bei überraschendem Besuch von Freunden oder unerwarteter Rückkehr von Mitbewohnerinnen). Darüber hinaus kann es vorkommen, dass die an einer BN erkrankten Personen Essanfälle gezielt planen (z. B. vorsorglich einkaufen, um abends nach der Rückkehr von der Arbeit genügend Nahrungsmittel für einen Essanfall zu haben).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Abgesehen von den Erst- und Letztautorinnen erfolgte die Reihung der Co-Autoren alphabetisch. Es wird ausschließlich die weibliche Form verwandt, da wir die gleichzeitige Nennung der weiblichen und männlichen Form von Patient wenig leserfreundlich finden und die Patienten dieser Zielgruppe mehrheitlich weiblich sind. Mitgemeint sind selbstverständlich auch männliche Patienten. In allen anderen Fällen wird dagegen ausschließlich die männliche Form verwandt (z. B. Therapeut, Diagnostiker), wobei auch in diesen Fällen bei Geschlechter gemeint sind.
- 2.
In den Kapiteln IV. (Anorexia nervosa) und VI. (Binge-Eating-Störung) als Selbsthilfe bezeichnet.
- 3.
Der Evidenzgrad entspricht einer Extrapolation von Evidenzen aus Studien im Erwachsenenbereich, die teilweise Jugendliche mit BN eingeschlossen haben, denen eine Behandlung angeboten wurde, die den Behandlungen für Erwachsene mit BN vergleichbar war.
Literatur
Agras, W. S., Dorian, B., Krikley, B., Arnow, B., & Bachmann, J. (1987). Imipramin in the treatment of bulimia: A double-blind controlled trial. International Journal of Eating Disorders, 6(1), 29–38.
Agras, W. S., Schneider, J. A., Arnow, B., Raeburn, S. D., & Telch, C. F. (1989). Cognitive-behavioral and response-prevention treatments for bulimia nervosa. Journal of Consulting and Clinical Psychology, 57(2), 215–221.
Agras, W. S., Rossiter, E., Arnow, B., Schneider, J., Telch, C. F., Raeburn, S., Bruce, B., Perl, M., & Koran, L. (1992). Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. American Journal of Psychiatry, 149(1), 82–87.
Agras, W. S., Crow, S. J., Halmi, K. A., Mitchell, J. E., Wilson, G. T., & Kraemer, H. C. (2000a). Outcome predictors for the cognitive behavior treatment of bulimia nervosa: Data from a multisite study. American Journal of Psychiatry, 157(8), 1302–1308.
Agras, W. S., Walsh, B. T., Fairburn, C. G., Wilson, G. T., & Kraemer, H. C. (2000b). A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Archives of General Psychiatry, 57(5), 459–466.
Aigner, M., Treasure, J., Kaye, W., Kasper, S., & WFSBP Task Force on Eating Disorders (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. The World Journal of Biological Psychiatry, 12(6), 400–443.
Allen, K. L., Byrne, S. M., Oddy, W. H., & Crosby, R. D. (2013). Early onset binge eating and purging eating disorders: Course and outcome in a population-based study of adolescents. Journal of Abnormal Child Psychology, 41(7), 1083–1096.
American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders, fifth edition: DSM 5. Washington, DC: Author.
Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Archives of General Psychiatry, 68(7), 724–731.
AWMF. (2010). Leitlinien-Detailansicht: Diagnostik und Therapie von Ess-Störungen. http://www.awmf.org/leitlinien/detail/ll/051-026.html
Bacaltchuk, J., & Hay, P. (2003). Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database of Systematic Reviews, 4, CD003391.
Bacaltchuk, J., Trefiglio, R. P., Oliveira, I. R., Hay, P., Lima, M. S., & Mari, J. J. (2000). Combination of antidepressants and psychological treatments for bulimia nervosa: A systematic review. Acta Psychiatrica Scandinavica, 101(4), 256–264.
Bachar, E., Latzer, Y., Kreitler, S., & Berry, E. M. (1999). Empirical comparison of two psychological therapies: Self psychology and cognitive orientation in the treatment of anorexia and bulimia. The Journal of Psychotherapy Practice and Research, 8(2), 115.
Bailer, U., de Zwaan, M., Leisch, F., Strnad, A., Lennkh-Wolfsberg, C., El-Giamal, N., Hornik, K., & Kasper, S. (2004). Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa. International Journal of Eating Disorders, 35(4), 522–537.
Banasiak, S. J., Paxton, S. J., & Hay, P. (2005). Guided self-help for bulimia nervosa in primary care: A randomized controlled trial. Psychological Medicine, 35(9), 1283–1294.
Barlow, J., Blouin, J., Blouin, A., & Perez, E. (1988). Treatment of bulimia with desipramine: A double-blind crossover study. The Canadian Journal of Psychiatry, 33(2), 129–133.
Beintner, I., & Jacobi, C. (2017). Selbsthilfe in der Behandlung von Essstörungen. Psychotherapeut, 62, 183–193.
Berg, K. C., Crosby, R. D., Cao, L., Peterson, C. B., Engel, S. G., Mitchell, J. E., & Wonderlich, S. A. (2013). Facets of negative affect prior to and following binge-only, purge-only, and binge/purge events in women with bulimia nervosa. Journal of Abnormal Psychology, 122(1), 111–118.
Beumont, P. J., Russell, J. D., Touyz, S. W., Buckley, C., Lowinger, K., Talbot, P., & Johnson, G. F. (1997). Intensive nutritional counselling in bulimia nervosa: A role for supplementation with fluoxetine? Australian and New Zealand Journal of Psychiatry, 31(4), 514–524.
Blouin, A., Blouin, J., Perez, E., Bushnik, T., Zuro, C., & Mulder, E. (1988). Treatment of bulimia with fenfluramine. Journal of Clinical Psychopharmacology, 8(4), 261–269.
Bogh, E. H., Rokkedal, K., & Valbak, K. (2005). A 4-year follow-up on bulimia nervosa. European Eating Disorders Review, 13(1), 48–53.
Bottin, J., Salbach-Andrae, H., Schneider, N., Pfeiffer, E., Lenz, K., & Lehmkuhl, U. (2010). Personality disorders in adolescent patients with anorexia and bulimia nervosa. Zeitschrift Fur Kinder-Und Jugendpsychiatrie Und Psychotherapie, 38(5), 341–350.
Bulik, C. M., & Tozzi, F. (2004). Genetics in eating disorders: State of the science. CNS Spectrums, 9(7), 511–515.
Bulik, C. M., Sullivan, P., Carter, F., McIntosh, V., & Joyce, P. (1998a). The role of exposure with response prevention in the cognitive-behavioural therapy for bulimia nervosa. Psychological Medicine, 28(3), 611–623.
Bulik, C. M., Sullivan, P. F., Joyce, P. R., Carter, F. A., & McIntosh, V. V. (1998b). Predictors of 1-year treatment outcome in bulimia nervosa. Comprehensive Psychiatry, 39(4), 206–214.
Bulik, C. M., Sullivan, P. F., Carter, F. A., McIntosh, V. V., & Joyce, P. R. (1999). Predictors of rapid and sustained response to cognitive-behavioral therapy for bulimia nervosa. International Journal of Eating Disorders, 26(2), 137–144.
Bulik, C. M., Sullivan, P. F., Wade, T. D., & Kendler, K. S. (2000). Twin studies of eating disorders: A review. International Journal of Eating Disorders, 27(1), 1–20.
Cagar-Nazai, H. P., Corfield, F., Cardi, V., Ambwani, S., Leppanen, J., Olabintan, O., Deriziotis, S., Hadjimichalis, A., Scognamiglio, P., Eshkevari, E., Micali, N., & Treasure, J. (2014). A systematic review and meta-analysis of ‚Systems for Social Processes‘ in eating disorders. Neuroscience and Biobehavioral Reviews, 42, 55–92.
Carruba, M., Cuzzolaro, M., Riva, L., Bosello, O., Liberti, S., Castra, R., Grave, R., Santonastaso, P., Garosi, V., & Nisoli, E. (2001). Efficacy and tolerability of moclobemide in bulimia nervosa: A placebo-controlled trial. International Clinical Psychopharmacology, 16(1), 27–32.
Carter, J. C., Olmsted, M. P., Kaplan, A. S., McCabe, R. E., Mills, J. S., & Aimé, A. (2003). Self-help for bulimia nervosa: A randomized controlled trial. American Journal of Psychiatry, 160(5), 973–978.
Castellini, G., Lo Sauro, C., Mannucci, E., Ravaldi, C., Rotella, C. M., Faravelli, C., & Ricca, V. (2011). Diagnostic crossover and outcome predictors in eating disorders according to DSM-IV and DSM-V proposed criteria: A 6-year follow-up study. Psychosomatic Medicine, 73(3), 270–279.
Chen, E., Touyz, S. W., Beumont, P. J., Fairburn, C. G., Griffiths, R., Butow, P., Russel, J., Fairburn, C. G., Gertler, R., & Basten, C. (2003). Comparison of group and individual cognitive-behavioral therapy for patients with bulimia nervosa. International Journal of Eating Disorders, 33(3), 241–254.
Chen, H., Cohen, P., & Chen, S. (2010). How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Communications in Statistics: Simulation and Computation, 39(4), 860–864.
Ciao, A. C., Accurso, E. C., Fitzsimmons-Craft, E. E., & Le Grange, D. (2015). Predictors and moderators of psychological changes during the treatment of adolescent bulimia nervosa. Behaviour Research and Therapy, 69, 48–53. https://doi.org/10.1016/j.brat.2015.04.002.
Cooper, P. J., & Steere, J. (1995). A comparison of two psychological treatments for bulimia nervosa: Implications for models of maintenance. Behaviour Research and Therapy, 33(8), 875–885.
Couturier, J., & Lock, J. (2007). A review of medication use for children and adolescents with eating disorders. Journal of Canadian Academy of Child and Adolescent Psychiatry, 16(4), 173–176.
Cuijpers, P., & Schuurmans, J. (2007). Self-help interventions for anxiety disorders: An overview. Current Psychiatry Reports, 9(4), 284–290.
Davis, H., & Attia, E. (2017). Pharmacotherapy of eating disorders. Current Opinion in Psychiatry, 30 (6), 452-457.
Davis, R., & McVey, G. (1999). Sequencing of cognitive-behavioral treatments for bulimia nervosa. International Journal of Eating Disorders, 25(4), 361–374.
Dilling, H., Mombour, W., & Schmidt, M. H. (2013). Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien (9. Aufl.). Goettingen: Huber.
Dodge, E., Hodes, M., Eisler, I., & Dare, C. (1995). Family-therapy for bulimia-nervosa in adolescents – An exploratory-study. Journal of Family Therapy, 17(1), 59–77.
Durand, M. A., & King, M. (2003). Specialist treatment versus self-help for bulimia nervosa: A randomised controlled trial in general practice. The British Journal of General Practice, 53(490), 371–377.
Esplen, M., Garfinkel, P., Olmsted, M., Gallop, R., & Kennedy, S. (1998). A randomized controlled trial of guided imagery in bulimia nervosa. Psychological Medicine, 28(6), 1347–1357.
Fahy, T. A., Eisler, I., & Russell, G. F. (1993). A placebo-controlled trial of d-fenfluramine in bulimia nervosa. The British Journal of Psychiatry, 162(5), 597–603.
Fairburn, C. G. (2008). Essattacken stoppen. Ein Selbsthilfeprogramm. Bern: Huber.
Fairburn, C. G., Kirk, J., O’Connor, M., & Cooper, P. J. (1986). A comparison of two psychological treatments for bulimia nervosa. Behaviour Research and Therapy, 24(6), 629–643.
Fairburn, C. G., Jones, R., Peveler, R. C., Carr, S. J., Solomon, R. A., O’Connor, M. E., Burton, J., & Hope, R. (1991). Three psychological treatments for bulimia nervosa: A comparative trial. Archives of General Psychiatry, 48(5), 463–469.
Fairburn, C. G., Jones, R., Preveler, R., Hope, R., & O’Connor, M. (1993). Psychotherapy and Bulimia Nervosa – Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Archives of General Psychiatry, 50, 419–428.
Fairburn, C. G., Welch, S. L., Doll, H. A., Davies, B. A., & O’Connor, M. E. (1997). Risk factors for bulimia nervosa. A community-based case-control study. Archives of General Psychiatry, 54(6), 509–517.
Fairburn, C. G., Doll, H. A., Welch, S. L., Hay, P. J., Davies, B. A., & O’Connor, M. E. (1998). Risk factors for binge eating disorder – A community-based, case-control study. Archives of General Psychiatry, 55(5), 425–432.
Fairburn, C. G., Cooper, Z., Doll, H. A., & Welch, S. L. (1999). Risk factors for anorexia nervosa – Three integrated case-control comparisons. Archives of General Psychiatry, 56(5), 468–476.
Fairburn, C. G., Cooper, Z., Doll, H. A., Norman, P., & O’Connor, M. (2000). The natural course of bulimia nervosa and binge eating disorder in young women. Archives of General Psychiatry, 57(7), 659–665.
Fairburn, C. G., Stice, E., Cooper, Z., Doll, H. A., Norman, P. A., & O’Connor, M. E. (2003). Understanding persistence in bulimia nervosa: A 5-year naturalistic study. Journal of Consulting and Clinical Psychology, 71(1), 103–109.
Fairburn, C. G., Agras, W. S., Walsh, B. T., Wilson, G. T., & Stice, E. (2004). Prediction of outcome in bulimia nervosa by early change in treatment. American Journal of Psychiatry, 161(12), 2322–2324.
Faris, P. L., Kim, S. W., Meller, W. H., Goodale, R. L., Oakman, S. A., Hofbauer, R. D., Marshall, A. M., Daughters, R. S., Banerjee-Stevens, D., Eckert, E. D., & Hartman, B. K. (2000). Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial. The Lancet, 355(9206), 792–797.
Fichter, M., & Quadflieg, N. (1997). Six-year course of bulimia nervosa. International Journal of Eating Disorders, 22(4), 361–384.
Fichter, M., & Quadflieg, N. (2004). Twelve-year course and outcome of bulimia nervosa. Psychological Medicine, 34(8), 1395–1406.
Fichter, M., & Quadflieg, N. (2007). Long-term stability of eating disorder diagnoses. International Journal of Eating Disorders, 40 Suppl, S61–S66.
Fichter, M., Leibl, K., Rief, W., Brunner, E., Schmidt-Auberger, S., & Engel, R. R. (1991). Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry, 24(1), 1–7.
Fichter, M., Kruger, R., Rief, W., Holland, R., & Dohne, J. (1996). Fluvoxamine in prevention of relapse in bulimia nervosa: Effects on eating-specific psychopathology. Journal of Clinical Psychopharmacology, 16(1), 9–18.
Fichter, M., Quadflieg, N., & Hedlund, S. (2008). Long-term course of binge eating disorder and bulimia nervosa: Relevance for nosology and diagnostic criteria. International Journal of Eating Disorders, 41(7), 577–586.
Flament, M. F., Bissada, H., & Spettigue, W. (2012). Evidence-based pharmacotherapy of eating disorders. International Journal of Neuropsychopharmacology, 15(2), 189–207.
Fluoxetine Bulimia Nervosa Collaborative Study Group (1992). Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Archives of General Psychiatry, 49(2), 139–147.
Garner, D. M., Rockert, W., & Davis, R. (1993). Therapy for bulimia nervosa. The American Journal of Psychiatry, 150(1), 37–46.
Ghaderi, A. (2006). Does individualization matter? A randomized trial of standardized (focused) versus individualized (broad) cognitive behavior therapy for bulimia nervosa. Behaviour Research and Therapy, 44(2), 273–288.
Goldbloom, D. S., Olmsted, M., Davis, R., Clewes, J., Heinmaa, M., Rockert, W., & Shaw, B. (1997). A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: Short-term outcome. Behaviour Research and Therapy, 35(9), 803–811.
Goldschmidt, A. B., Wonderlich, S. A., Crosby, R. D., Engel, S. G., Lavender, J. M., Peterson, C. B., Scott, J. C., Li, C., & Mitchell, J. E. (2014). Ecological momentary assessment of stressful events and negative affect in bulimia nervosa. Journal of Consulting and Clinical Psychology, 82(1), 30–39.
Goldstein, D. J., Wilson, M. G., Thompson, V. L., Potvin, J. H., & Rampey, A. H., Jr. (1995). Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. British Journal of Psychiatry, 166(5), 660–666.
Griffiths, R. A., Hadzi-Pavlovic, D., & Channon-Little, L. (1994). A controlled evaluation of hypnobehavioural treatment for bulimia nervosa: Immediate pre-post treatment effects. European Eating Disorders Review, 2(4), 202–220.
Haddock, C., Rindskopf, D., & Shadish, W. R. (1998). Using odds ratios as effect sizes for meta-analysis of dichotomous data: A primer on methods and issues. Psychological Methods, 3(3), 339–353.
Haedt-Matt, A. A., & Keel, P. K. (2011a). Hunger and binge eating: A meta-analysis of studies using ecological momentary assessment. International Journal of Eating Disorders, 44(7), 573–578.
Haedt-Matt, A. A., & Keel, P. K. (2011b). Revisiting the affect regulation model of binge eating: A meta-analysis of studies using ecological momentary assessment. Psychological Bulletin, 137(4), 660–681.
Hedges, D. W., Reimherr, F. W., Hoopes, S. P., Rosenthal, N. R., Kamin, M., Karim, R., & Capece, J. A. (2003). Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: Improvement in psychiatric measures. Journal of Clinical Psychiatry, 64(12), 1449–1454.
Helverskov, J. L., Clausen, L., Mors, O., Frydenberg, M., Thomsen, P. H., & Rokkedal, K. (2010). Trans-diagnostic outcome of eating disorders: A 30-month follow-up study of 629 patients. European Eating Disorders Review, 18(6), 453–463.
Herzog, D. B., Dorer, D. J., Keel, P. K., Selwyn, S. E., Ekeblad, E. R., Flores, A. T., Greenwood, D. N., Burwell, R. A., & Keller, M. B. (1999). Recovery and relapse in anorexia and bulimia nervosa: A 7.5-year follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry, 38(7), 829–837.
Hilbert, A., Pike, K. M., Goldschmidt, A. B., Wilfley, D. E., Fairburn, C. G., Dohm, F. A., Walsh, B. T., & Weissman, R. S. (2014). Risk factors across the eating disorders. Psychiatry Research, 220(1–2), 500–506.
Hill, D. M., Craighead, L. W., & Safer, D. L. (2011). Appetite-focused dialectical behavior therapy for the treatment of binge eating with purging: A preliminary trial. International Journal of Eating Disorders, 44(3), 249–261.
Holmes, M., Fuller-Tyszkiewicz, M., Skouteris, H., & Broadbent, J. (2014). Improving prediction of binge episodes by modelling chronicity of dietary restriction. European Eating Disorders Review, 22(6), 405–411.
Hoopes, S. P., Reimherr, F. W., Hedges, D. W., Rosenthal, N. R., Kamin, M., Karim, R., Capece, J. A., & Karvois, D. (2003). Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: Improvement in binge and purge measures. The Journal of Clinical Psychiatry, 64(11), 1335–1341.
Horne, R. L., Ferguson, J. M., Pope, H. G., Jr., Hudson, J. I., Lineberry, C. G., Ascher, J., & Cato, A. (1988). Treatment of bulimia with bupropion: A multicenter controlled trial. Journal of Clinical Psychiatry, 49(7), 262–266.
Hsu, L. K., Clement, L., Santhouse, R., & Ju, E. S. (1991). Treatment of bulimia nervosa with lithium carbonate. A controlled study. Journal of Nervous and Mental Disease, 179(6), 351–355.
Hsu, L., Rand, W., Sullivan, S., Liu, D., Mulliken, B., McDonagh, B., & Kaye, W. (2001). Cognitive therapy, nutritional therapy and their combination in the treatment of bulimia nervosa. Psychological Medicine, 31(5), 871–879.
Hudson, J. I., Hiripi, E., Pope, H. G., Jr., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61(3), 348–358.
Hughes, P. L., Wells, L. A., Cunningham, C. J., & Ilstrup, D. M. (1986). Treating bulimia with desipramine: A double-blind, placebo-controlled study. Archives of General Psychiatry, 43(2), 182–186.
Huseman, C., Pearson, P., Madison, J., & Leuschen, M. (1990). Bulimia as a form of self-addiction-treatment with naltrexone hydrochloride (trexan)-a pilot study. Clinical Trials Journal, 27(2), 77–83.
Jacobi, C., Dahme, B., & Dittmann, R. (2002). Cognitive-behavioural, fluoxetine and combined treatment for bulimia nervosa: Short- and long-term results. European Eating Disorders Review, 10(3), 179–198.
Jacobi, C., Jäger, B., Kersting, A., Rustenbach, S. J., Salbach-Andrae, H., von Wietersheim, J., Herpertz, S., & de Zwaan, M. (2011). Bulimia nervosa. In S. Herpertz, B. Herpertz-Dahlmann, M. Fichter, B. Tuschen-Caffier, & A. Zeeck (Hrsg.), S3-Leitlinie. Diagnostik und Behandlung der Essstörungen (S. 157–202). Berlin: Springer.
Jaite, C., Hoffmann, F., Glaeske, G., & Bachmann, C. J. (2013). Prevalence, comorbidities and outpatient treatment of anorexia and bulimia nervosa in German children and adolescents. Eating and Weight Disorders-Studies on Anorexia Bulimia and Obesity, 18(2), 157–165.
Kanerva R., Rissanen A., & Sarna S. (1995). Fluoxetine in the Treatment of Anxiety, Depressive Symptoms, and Eating-Related Symptoms in Bulimia-Nervosa. Nordic Journal of Psychiatry, 49(4), 237–242.
Keel, P. K., Dorer, D. J., Franko, D. L., Jackson, S. C., & Herzog, D. B. (2005). Postremission predictors of relapse in women with eating disorders. American Journal of Psychiatry, 162(12), 2263–2268.
Keel, P. K., Gravener, J. A., Joiner, T. E., & Haedt, A. A. (2010). Twenty-year follow-up of bulimia nervosa and related eating disorders not otherwise specified. International Journal of Eating Disorders, 43(6), 492–497.
Kennedy, S. H., Goldbloom, D., Ralevski, E., Davis, C., D’souza, J., & Lofchy, J. (1993). Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. Journal of Clinical Psychopharmacology, 13(6), 415–422.
Keski-Rahkonen, A., Raevuori, A., Bulik, C. M., Hoek, H. W., Sihvola, E., Kaprio, J., & Rissanen, A. (2013). Depression and drive for thinness are associated with persistent bulimia nervosa in the community. European Eating Disorders Review, 21(2), 121–129.
Kotler, L. A., Devlin, M. J., Davies, M., & Walsh, B. T. (2003). An open trial of fluoxetine for adolescents with bulimia nervosa. Journal of Child and Adolescent Psychopharmacology, 13(3), 329–335.
Laessle, R. G., Waadt, S., & Pirke, K. M. (1987). A structured behaviorally oriented group treatment for bulimia nervosa. Psychotherapy and Psychosomatics, 48(1–4), 141–145.
Laessle, R., Beumont, P., Butow, P., Lennerts, W., O’Connor, M., Pirke, K., Touyz, S., & Waadt, S. (1991). A comparison of nutritional management with stress management in the treatment of bulimia nervosa. The British Journal of Psychiatry, 159(2), 250–261.
Lavender, A., Startup, H., Naumann, U., Samarawickrema, N., Dejong, H., Kenyon, M., van den Eynde, F., & Schmidt, U. (2012). Emotional and social mind training: A randomised controlled trial of a new group-based treatment for bulimia nervosa. PLoS One, 7(10), e46047.
Le Grange, D., Lock, J., & Dymek, M. (2003). Family-based therapy for adolescents with bulimia nervosa. American Journal of Psychotherapy, 57(2), 237–251.
Le Grange, D., Crosby, R. D., Rathouz, P. J., & Leventhal, B. L. (2007). A Randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa. Archives of General Psychiatry, 64(9), 1049–1056.
Le Grange, D., Crosby, R. D., & Lock, J. (2008). Predictors and moderators of outcome in family-based treatment for adolescent bulimia nervosa. Journal of the American Academy of Child and Adolescent Psychiatry, 47(4), 464–470.
Le Grange, D., Lock, J., Agras, W. S., Bryson, S. W., & Jo, B. (2015). Randomized clinical trial of family-based treatment and cognitive-behavioral therapy for adolescent bulimia nervosa. J Am Acad Child Adolesc Psychiatry, 54(11), 886–894.e882.
Lee, N. F., & Rush, A. J. (1986). Cognitive-behavioral group therapy for bulimia. International Journal of Eating Disorders, 5(4), 599–615.
Leitenberg, H., Rosen, J. C., Wolf, J., Vara, L. S., Detzer, M. J., & Srebnik, D. (1994). Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Behaviour Research and Therapy, 32(1), 37–45.
Leombruni, P., Amianto, F., Delsedime, N., Gramaglia, C., Abbate-Daga, G., & Fassino, S. (2006). Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: A single-blind randomized controlled trial. Advances in Therapy, 23(3), 481–494.
Levine, L. R. (1992). Fluoxetine in the treatment of bulimia nervosa. a multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Archives of General Psychiatry, 49(2), 139–147.
Lock, J. (2005). Adjusting cognitive behavioral therapy for adolescent bulimia nervosa: Results of a case series. American Journal of Psychotherapy, 59(3), 267–281.
Lock, J., Le Grange, D., Agras, W., & Dare, C. (2001). Treatment manual for anorexia nervosa: A family-based approach. New York: Guilford Press.
Lock, J., Agras, W. S., Le Grange, D., Couturier, J., Safer, D., & Bryson, S. W. (2013). Do end of treatment assessments predict outcome at follow-up in eating disorders? International Journal of Eating Disorders, 46(8), 771–778.
Magallon-Neri, E., Gonzalez, E., Canalda, G., Forns, M., De La Fuente, J. E., Martinez, E., García, R., Lara, A., Vallès, A., & Castro-Fornieles, J. (2014). Prevalence and severity of categorical and dimensional personality disorders in adolescents with eating disorders. European Eating Disorders Review, 22(4), 306.
Mauler, B. I., Hamm, A. O., Weike, A. I., & Tuschen-Caffier, B. (2006). Affect regulation and food intake in bulimia nervosa: Emotional responding to food cues after deprivation and subsequent eating. Journal of Abnormal Psychology, 115(3), 567–579.
McCann, U. D., & Agras, W. S. (1990). Successful treatment of nonpurging bulimia nervosa with desipramine: A double-blind, placebo-controlled study. The American Journal of Psychiatry, 147(11), 1509.
Milano, W., Petrella, C., Sabatino, C., & Capasso, A. (2004). Treatment of bulimia nervosa with sertraline: A randomized controlled trial. Advances in Therapy, 21(4), 232–237.
Milano, W., Siano, C., Putrella, C., & Capasso, A. (2005). Treatment of bulimia nervosa with fluvoxamine: A randomized controlled trial. Advances in Therapy, 22(3), 278–283.
Mitchell, J. E., Christenson, G., Jennings, J., Huber, M., Thomas, B., Pomeroy, C., & Morley, J. (1989). A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. Journal of Clinical Psychopharmacology, 9(2), 94–97.
Mitchell, J. E., Pyle, R. L., Eckert, E. D., Zollman, M., Crosby, R., Zimmerman, R., Eckert, E. D., & Seim, H. (1993). Cognitive-behavioral group psychotherapy of bulimia nervosa: Importance of logistical variables. International Journal of Eating Disorders, 14(3), 277–287.
Mitchell, J. E., Fletcher, L., Hanson, K., Mussell, M. P., Seim, H., Crosby, R., & Al-Banna, M. (2001). The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa. Journal of Clinical Psychopharmacology, 21(3), 298–304.
Mitchell J. E., Halmi K., Wilson G. T., Agras W. S., Kraemer H., & Crow S. (2002). A randomized secondary treatment study of women with bulimia nervosa who fail to respond to CBT International Journal of Eating Disorders; 32(3), 271–281.
Mitchell, J. E., Agras, S., Crow, S., Halmi, K., Fairburn, C. G., Bryson, S., & Kraemer, H. (2011). Stepped care and cognitive-behavioural therapy for bulimia nervosa: Randomised trial. The British Journal of Psychiatry, 198(5), 391–397.
Mitchell, J. E., Roerig, J., & Steffen, K. (2013). Biological therapies for eating disorders. International Journal of Eating Disorders, 46(5), 470–477.
Nagl, M., Jacobi, C., Paul, M., Beesdo-Baum, K., Höfler, M., Lieb, R., & Wittchen, H.-U. (2016). Prevalence, incidence, and natural course of anorexia and bulimia nervosa among adolescents and young adults. European Child and Adolescent Psychiatry, 25(8), 903-918.
Naumann, E., Tuschen-Caffier, B., Voderholzer, U., Caffier, D., & Svaldi, J. (2015). Rumination but not distraction increases eating-related symptoms in anorexia and bulimia nervosa. Journal of Abnormal Psychology, 124(2), 412–420.
Nazar, B. P., Bernardes, C., Peachey, G., Sergeant, J., Mattos, P., & Treasure, J. (2016). The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. International Journal of Eating Disorders, 49(12), 1045–1057.
Nickel, C., Tritt, K., Muehlbacher, M., Pedrosa Gil, F., Mitterlehner, F. O., Kaplan, P., Lahmann, C., Leiberich, P. K., Krawczyk, J., Kettler, C., Rother, W. K., Loew, T. H., & Nickel, M. K. (2005). Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial. International Journal of Eating Disorders, 38(4), 295–300.
Nolen-Hoeksema, S., Stice, E., Wade, E., & Bohon, C. (2007). Reciprocal relations between rumination and bulimic, substance abuse, and depressive symptoms in female adolescents. Journal of Abnormal Psychology, 116(1), 198–207.
Olmsted, M. P., Kaplan, A. S., Rockert, W., & Jacobsen, M. (1996). Rapid responders to intensive treatment of bulimia nervosa. International Journal of Eating Disorders, 19(3), 279–285.
Ordman, A. M., & Kirschenbaum, D. S. (1985). Cognitive-behavioral therapy for bulimia: An initial outcome study. Journal of Consulting and Clinical Psychology, 53(3), 305.
Phillips, B., Ball, C., Sackett, D., Badenoch, D., Straus, S., Haynes, B., & Dawes, M. (1998–2009). Oxford centre for evidence-based medicine – Levels of evidence (March 2009). http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ Zugegriffen am 14.10.2019
Pinhas-Hamiel, O., & Levy-Shraga, Y. (2013). Eating disorders in adolescents with type 2 and type 1 diabetes. Current Diabetes Reports, 13(2), 289–297.
Pinhas-Hamiel, O., Hamiel, U., & Levy-Shraga, Y. (2015). Eating disorders in adolescents with type 1 diabetes: Challenges in diagnosis and treatment. World Journal of Diabetes, 6(3), 517–526.
Pope, H. G., Hudson, J. I., Jonas, J. M., & Yurgelun-Todd, D. (1983). Bulimia treated with imipramine: A placebo-controlled, double-blind study. The American Journal of Psychiatry, 140(5), 554–558.
Pope, J. H., Keck, J. P., McELROY, S. L., & Hudson, J. I. (1989). A placebo-controlled study of trazodone in bulimia nervosa. Journal of Clinical Psychopharmacology, 9(4), 254–259.
Poulsen, S., Lunn, S., Daniel, S. I., Folke, S., Mathiesen, B. B., Katznelson, H., & Fairburn, C. G. (2014). A randomized controlled trial of psychoanalytic psychotherapy or cognitive-behavioral therapy for bulimia nervosa. American Journal of Psychiatry, 171(1), 109–116.
Preti, A., de Girolamo, G., Vilagut, G., Alonso, J., de Graaf, R., Bruffaerts, R., Demyttenaere, K., Pinto-Meza, A., Haro, J. M., Morosini, P., & The ESEMeD-WMH- Investigators (2009). The epidemiology of eating disorders in six European countries: Results of the ESEMeD-WMH project. Journal of Psychiatric Research, 43(14), 1125–1132.
Preti, A., Rocchi, M. B. L., Sisti, D., Camboni, M. V., & Miotto, P. (2011). A comprehensive meta-analysis of the risk of suicide in eating disorders. Acta Psychiatrica Scandinavica, 124(1), 6–17.
Romano, S. J., Halmi, K. A., Sarkar, N. P., Koke, S. C., & Lee, J. S. (2002). A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. American Journal of Psychiatry, 159(1), 96–102.
Russell, G., Checkley, S., Feldman, J., & Eisler, I. (1988). A controlled trial of d-fenfluramine in bulimia nervosa. Clinical Neuropharmacology, 11, S146–S159.
Safer, D. L., Telch, C. F., & Agras, W. S. (2001). Dialectical behavior therapy for bulimia nervosa. American Journal of Psychiatry, 158(4), 632–634.
Sawilowsky, S. (2009). New effect size rules of thumb. Journal of Modern Applied Statistical Methods, 8(2), 467–474.
Schmidt, U., Cooper, P. J., Essers, H., Freeman, C. P., Holland, R. L., Palmer, R. L., Shur, E., Russell, G. F. M., Bowler, C., & Coker, S. (2004). Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: A randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy. Journal of Clinical Psychopharmacology, 24(5), 549–552.
Schmidt, U., Lee, S., Beecham, J., Perkins, S., Treasure, J., Yi, I., Winn, S., Robinson, P., Murphy, R., Keville, S., Johnson-Sabine, E., Jenkins, M., Frost, S., Dodge, L., Berelowitz, M., & Eisler, I. (2007). A randomized controlled trial of family therapy and cognitive behavior therapy guided self-care for adolescents with bulimia nervosa and related disorders. American Journal of Psychiatry, 164(4), 591–598.
Schmidt, U., Lee, S., Perkins, S., Eisler, I., Treasure, J., Beecham, J., Berelowitz, M., Dodge, L., Frost, S., Jenkins, M., Johnson-Sabine, E., Keville, S., Murphy, R., Robinson, P., Winn, S., & Yi, I. (2008). Do adolescents with eating disorder not otherwise specified or full-syndrome bulimia nervosa differ in clinical severity, comorbidity, risk factors, treatment outcome or cost? International Journal of Eating Disorders, 41(6), 498–504.
Schmidt, U., Treasure, J., & Alexander, J. (2016). Die Bulimie besiegen. Ein Selbsthilfe-Programm. Weinheim: Beltz.
Schutzmann, K., Schutzmann, M., & Eckert, J. (2010). The efficacy of outpatient client-centered psychotherapy for bulimia nervosa: Results of a randomised controlled trial. Psychotherapie, Psychosomatik, Medizinische Psychologie, 60(2), 52–63.
Sloan, D. M., Mizes, J. S., Helbok, C., & Muck, R. (2004). Efficacy of sertraline for bulimia nervosa. International Journal of Eating Disorders, 36(1), 48–54.
Stefini, A., Salzer, S., Reich, G., Horn, H., Winkelmann, K., Bents, H., Rutz, U., Frost, U., von Boetticher, A., Ruhl, U., Specht, N., & Kronmuller, K. T. (2017). Cognitive-behavioral and psychodynamic therapy in female adolescents with bulimia nervosa: A randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 56(4), 329–335.
Stice, E. (2001). A prospective test of the dual-pathway model of bulimic pathology: Mediating effects of dieting and negative affect. Journal of Abnormal Psychology, 110(1), 124–135.
Stice, E. (2016). Interactive and mediational etiologic models of eating disorder onset: Evidence from Prospective Studies. Annual Review of Clinical Psychology, 12, 359–381. https://doi.org/10.1146/annurev-clinpsy-021815-093317.
Stice, E., Shaw, H., & Nemeroff, C. (1998). Dual pathway model of bulimia nervosa: Longitudinal support for dietary restraint and affect-regulation mechanisms. Journal of Social and Clinical Psychology, 17(2), 129–149.
Stice, E., Marti, C. N., Shaw, H., & Jaconis, M. (2009). An 8-year longitudinal study of the natural history of threshold, subthreshold, and partial eating disorders from a community sample of adolescents. Journal of Abnormal Psychology, 118(3), 587–597.
Stice, E., Burger, K., & Yokum, S. (2013). Caloric deprivation increases responsivity of attention and reward brain regions to intake, anticipated intake, and images of palatable foods. NeuroImage, 67, 322–330.
Strasser, T. J., Pike, K. M., & Walsh, B. T. (1992). The impact of prior substance abuse on treatment outcome for bulimia nervosa. Addictive Behaviors, 17(4), 387–395.
Sullivan, P. F., Bulik, C. M., Carter, F. A., & Joyce, P. R. (1996). Correlates of severity in bulimia nervosa. International Journal of Eating Disorders, 20(3), 239–251.
Sundblad, C., Landen, M., Eriksson, T., Bergman, L., & Eriksson, E. (2005). Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa. Journal of Clinical Psychopharmacology, 25(1), 85–88.
Sundgot-Borgen, J., Rosenvinge, J. H., Bahr, R., & Schneider, L. S. (2002). The effect of exercise, cognitive therapy, and nutritional counseling in treating bulimia nervosa. Medicine and Science in Sports and Exercise, 34(2), 190–195.
Svaldi J, Schmitz F, Baur J,Hartmann AS, Legenbauer T, Thaler C, vonWietersheim J, de Zwaan M, Tuschen-Caffier B(2019). Efficacy of psychotherapies andpharmacotherapies for Bulimia nervosa. Psychological Medicine49, 898–910. doi: 10.1017/S0033291718003525
Svedlund, N. E., Norring, C., Ginsberg, Y., & von Hausswolff-Juhlin, Y. (2017). Symptoms of attention deficit hyperactivity disorder (ADHD) among adult eating disorder patients. BMC Psychiatry, 17, 19.
Swanson, S. A., Crow, S. J., Le Grange, D., Swendsen, J., & Merikangas, K. R. (2011). Prevalence and correlates of eating disorders in adolescents results from the national comorbidity survey replication adolescent supplement. Archives of General Psychiatry, 68(7), 714–723.
Thackwray, D. E., Smith, M. C., Bodfish, J. W., & Meyers, A. W. (1993). A comparison of behavioral and cognitive-behavioral interventions for bulimia nervosa. Journal of Consulting and Clinical Psychology, 61(4), 639.
Thiels, C., Schmidt, U., Treasure, J., Garthe, R., & Troop, N. (1998). Guided self-change for bulimia nervosa incorporating use of a self-care manual. American Journal of Psychiatry, 155(7), 947–953.
Thompson-Brenner, H., Shingleton, R. M., Sauer-Zavala, S., Richards, L. K., & Pratt, E. M. (2015). Multiple measures of rapid response as predictors of remission in cognitive behavior therapy for bulimia nervosa. Behaviour Research and Therapy, 64, 9–14.
Treasure, J., Schmidt, U., Troop, N., Tiller, J., Todd, G., Keilen, M., & Dodge, E. (1994). First step in managing bulimia nervosa: Controlled trial of therapeutic manual. BMJ, 308(6930), 686–689.
Ventura, M., & Bauer, B. (1999). Empowerment of women with purging-type bulimia nervosa through nutritional rehabilitation. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 4(2), 55–62.
Wagner, G., Penelo, E., Wanner, C., Gwinner, P., Trofaier, M. L., Imgart, H., Waldherr, K., Wöber-Bingöl, C., & Karwautz, A. F. (2013). Internet-delivered cognitive-behavioural therapy v. conventional guided self-help for bulimia nervosa: Long-term evaluation of a randomised controlled trial. British Journal of Psychiatry, 202, 135–141.
Wagner, G., Penelo, E., Nobis, G., Mayrhofer, A., Wanner, C., Schau, J., Spitzer, M., Gwinner, P., Trofaier, M.-L., Imgart, H., Fernandez-Aranda, F., & Karwautz, A. (2015). Predictors for good therapeutic outcome and drop-out in technology assisted guided self-help in the treatment of bulimia nervosa and bulimia like phenotype. European Eating Disorders Review, 23(2), 163–169.
Walsh, B. T., & Hadigan, C. M. (1991). Long-term outcome of antidepressant treatment for bulimia nervosa. The American Journal of Psychiatry, 148(9), 1206.
Walsh, B. T., Gladis, M., Roose, S. P., Stewart, J. W., Stetner, F., & Glassman, A. H. (1988). Phenelzine vs placebo in 50 patients with bulimia. Archives of General Psychiatry, 45(5), 471–475.
Walsh, B. T., Wilson, G. T., Loeb, K. L., Devlin, M. J., Pike, K. M., Roose, S. P., Fleiss, J., & Waternaux, C. (1997). Medication and psychotherapy in the treatment of bulimia nervosa. American Journal of Psychiatry, 154(4), 523–531.
Walsh, B. T., Agras, W. S., Devlin, M. J., Fairburn, C. G., Wilson, G. T., Kahn, C., & Chally, M. K. (2000). Fluoxetine for bulimia nervosa following poor response to psychotherapy. American Journal of Psychiatry, 157(8), 1332–1334.
von Wietersheim, J., Kordy, H., Kächele, H., & MZ-Ess (2004). Stationäre psychodynamische Behandlungsprogramme bei Essstörungen. Die multizentrische Studie zur psychodynamischen Therapie von Essstörungen (MZS). In W. Herzog, D. Munz, & H. Kächele (Hrsg.), Essstörungen. Therapieführer und psychodynamische Behandlungskonzepte (2. Aufl., S. 3–15). Stuttgart: Schattauer.
Williamson, D. A., Prather, R. C., Bennett, S. M., Davis, C. J., Watkins, P. C., & Grenier, C. E. (1989). An uncontrolled evaluation of inpatient and outpatient cognitive-behavior therapy for bulimia nervosa. Behavior Modification, 13(3), 340–360.
Wilson, G. T., Rossiter, E., Kleifield, E. I., & Lindholm, L. (1986). Cognitive-behavioral treatment of bulimia nervosa: A controlled evaluation. Behaviour Research and Therapy, 24(3), 277–288.
Wilson, G. T., Fairburn, C. C., Agras, W. S., Walsh, B. T., & Kraemer, H. (2002). Cognitive-behavioral therapy for bulimia nervosa: Time course and mechanisms of change. Journal of Consulting and Clinical Psychology, 70(2), 267–274.
Wolf, E. M., & Crowther, J. H. (1992). An evaluation of behavioral and cognitive-behavioral group interventions for the treatment of bulimia nervosa in women. International Journal of Eating Disorders, 11(1), 3–15.
Wonderlich, S. A., Peterson, C. B., Crosby, R. D., Smith, T. L., Klein, M. H., Mitchell, J. E., & Crow, S. J. (2014). A randomized controlled comparison of integrative cognitive-affective therapy (ICAT) and enhanced cognitive-behavioral therapy (CBT-E) for bulimia nervosa. Psychological Medicine, 44(3), 543–553.
Zeeck, A., Birindelli, E., Sandholz, A., Joos, A., Herzog, T., & Hartmann, A. (2007). Symptom severity and treatment course of bulimic patients with and without a borderline personality disorder. European Eating Disorders Review, 15(6), 430–438.
Zeeck, A., Weber, S., Sandholz, A., Wetzler-Burmeister, E., Wirsching, M., & Hartmann, A. (2009a). Inpatient versus day clinic treatment for bulimia nervosa: A randomized trial. Psychotherapy and Psychosomatics, 78(3), 152–160.
Zeeck, A., Weber, S., Sandholz, A., Wetzler-Burmeister, E., Wirsching, M., Scheidt, C. E., & Hartmann, A. (2009b). Inpatient versus day treatment for bulimia nervosa: Results of a one-year follow-up. Psychotherapy and Psychosomatics, 78(5), 317–319.
Zeeck, A., Weber, S., Sandholz, A., Joos, A., & Hartmann, A. (2011). Stability of long-term outcome in bulimia nervosa: A 3-year follow-up. Journal of Clinical Psychology, 67(3), 318–327.
Zerwas, S. C., Watson, H. J., Hofmeier, S. M., Levine, M. D., Hamer, R. M., Crosby, R. D., Runfola, C. D., Peat, C. M., Shapiro, J. R., Zimmer, B., Moessner, M., Kordy, H., Marcus, M. D., & Bulik, C. M. (2017). CBT4BN: A randomized controlled trial of online hhat and face-to-face group therapy for bulimia nervosa. Psychotherapy and Psychosomatics, 86(1), 47–53.
Zunker, C., Peterson, C. B., Crosby, R. D., Cao, L., Engel, S. G., Mitchell, J. E., & Wonderlich, S. A. (2011). Ecological momentary assessment of bulimia nervosa: Does dietary restriction predict binge eating? Behaviour Research and Therapy, 49(10), 714–717.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 DGPM, DGESS, DGPPN, DGKJP, DKPM, DGPs
About this chapter
Cite this chapter
Svaldi, J., Hartmann Firnkorn, A., Legenbauer, T., von Wietersheim, J., de Zwaan, M., Tuschen-Caffier, B. (2019). Bulimia nervosa. In: Herpertz, S., et al. S3-Leitlinie Diagnostik und Behandlung der Essstörungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59606-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-59606-7_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59605-0
Online ISBN: 978-3-662-59606-7
eBook Packages: Medicine (German Language)